Clinical trials
Phase 3 Gallbladder Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 2 |
| 2014 | 2 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 2 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Recruiting | 4 |
| Terminated | 3 |
| Active, not recruiting | 2 |
| Unknown status | 2 |
| Withdrawn | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 2 |
| Merck Sharp & Dohme LLC | 2 |
| NCIC Clinical Trials Group | 2 |
| University College, London | 2 |
| Emory University | 1 |
| Erasmus Medical Center | 1 |
| Fudan University | 1 |
| Helsinn Healthcare SA | 1 |
| INSYS Therapeutics Inc | 1 |
| J-Pharma Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gallbladder Neoplasms | 25 |
| Bile Duct Neoplasms | 13 |
| Cholangiocarcinoma | 11 |
| Biliary Tract Neoplasms | 6 |
| Carcinoma, Hepatocellular | 4 |
| Liver Neoplasms | 4 |
| Colonic Neoplasms | 3 |
| Pancreatic Neoplasms | 3 |
| Stomach Neoplasms | 3 |
| Appendiceal Neoplasms | 2 |
Trials
Showing 26 to 25 of 25. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.